Literature DB >> 8894497

Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles.

H Hara1, G Egusa, M Yamakido.   

Abstract

UNLABELLED: The incidence of non-insulin-dependent diabetes mellitus (NIDDM) and its risk factors were analysed from data of a follow-up study conducted on Japanese-Americans living in Hawaii and Los Angeles areas known to have a high prevalence of NIDDM. There were 1144 Japanese-Americans aged 40 years or more (mean (+/- SD) age: 60.7 +/- 10.1) available for follow-up, and who were non-diabetic based on glucose tolerance test (GTT) results conducted at the time of the initial examination. During the study period (6.3 +/- 3.2 yr), 124 cases of NIDDM occurred with an incidence rate as high as 10.8% or 17.2 persons per 1000 person-years. The incidence of NIDDM was 1.25 times higher in males than in females, and the rate increased with age. The incidence in obese people (body mass index: BMI > or = 25) was approximately twice that in the non-obese, the rate increasing with the level of obesity. Using Cox's proportional hazards model, the risk factors for NIDDM were analysed after adjusting for sex and age. Significant risk factors were the serum glucose (SG) level (fasting, 1-h, 2-h), the serum immuno-reactive insulin (IRI) level (1-h, 2-h) during GTT, BMI, serum triglycerides, high density lipoprotein (HDL)-cholesterol, serum uric acid, diastolic blood pressure, systolic blood pressure, serum total protein, and delta IRI/delta SG (0-30 min) level. In particular the hyperinsulinaemia was a significant risk factor even after adjusting for sex, age, and obesity. The incidence of NIDDM in the sub-group whose delta IRI/delta SG (0-30 min) level was under 0.3 was higher than that of the over 0.8 sub-group by a factor of approximately 12. Likewise, after dividing the subjects into five sub-groups according to the fasting or 2 h IRI level, the incidence of NIDDM was higher in the highest quintile than in the lowest quintile sub-group by a factor of approximately 3 and 7, respectively. The results of the GTT of the subjects who developed NIDDM during the follow-up period were analysed longitudinally and compared with the results obtained 8 years before occurrence of NIDDM. An increase in the 2-h serum IRI was observed initially, followed by an increase in the 2-h serum glucose level, preceding the appearance of NIDDM. IN
CONCLUSION: 1. A high incidence of NIDDM is clearly observed in the population of Japanese-Americans, who are genetically indistinguishable from native Japanese; causes of this increase, from the survey results, are suspected to include westernization of lifestyle, particularly the reduction in the level of physical activity, conversion to a diet containing markedly more animal fat, simple carbohydrates, and less complex carbohydrates. 2. In the Japanese-Americans, diminished early insulin release to an oral glucose challenge and increased insulin resistance characterized by hyperinsulinaemia are suspected to be some of the important risk factors for NIDDM. Consequently, this study strongly suggested the possibility that the development of NIDDM in Japanese persons may be influenced by environmental factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894497

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  16 in total

1.  Prevalence of diagnosed diabetes and related risk factors: Japanese adults in Westchester County, New York.

Authors:  Akiko S Hosler; Thomas A Melnik
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies.

Authors:  S Lillioja; A Wilton
Journal:  Diabetologia       Date:  2009-03-19       Impact factor: 10.122

3.  The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study.

Authors:  Shah Ebrahim; Sanjay Kinra; Liza Bowen; Elizabeth Andersen; Yoav Ben-Shlomo; Tanica Lyngdoh; Lakshmy Ramakrishnan; R C Ahuja; Prashant Joshi; S Mohan Das; Murali Mohan; George Davey Smith; Dorairaj Prabhakaran; K Srinath Reddy
Journal:  PLoS Med       Date:  2010-04-27       Impact factor: 11.069

4.  Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii.

Authors:  Beth N Hopping; Eva Erber; Andrew Grandinetti; Martijn Verheus; Laurence N Kolonel; Gertraud Maskarinec
Journal:  J Nutr       Date:  2009-11-04       Impact factor: 4.798

5.  "Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.

Authors:  Ken Yajima; Akira Shimada; Hiroshi Hirose; Akira Kasuga; Takao Saruta
Journal:  Rev Diabet Stud       Date:  2004-08-10

6.  Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis.

Authors:  Han-Gyul Yoo; Sang-Il Lee; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-12-20       Impact factor: 2.631

7.  The relationship of body mass index and waist-hip ratio on the 9-year incidence of diabetes and hypertension in a predominantly African-origin population.

Authors:  Barbara Nemesure; Suh-Yuh Wu; Anselm Hennis; M Cristina Leske
Journal:  Ann Epidemiol       Date:  2008-08       Impact factor: 3.797

8.  Longitudinal Trends in the Prevalence of Diabetes Mellitus in an Urban Emergency Department.

Authors:  Sarah A Sterling; Alan E Jones; Robert D Cox
Journal:  South Med J       Date:  2016-04       Impact factor: 0.954

9.  Evolutionary origins of insulin resistance: a behavioral switch hypothesis.

Authors:  Milind G Watve; Chittaranjan S Yajnik
Journal:  BMC Evol Biol       Date:  2007-04-17       Impact factor: 3.260

10.  Sib-recruitment for studying migration and its impact on obesity and diabetes.

Authors:  Tanica Lyngdoh; Sanjay Kinra; Yoav Ben Shlomo; Srinath Reddy; Dorairaj Prabhakaran; George Davey Smith; Shah Ebrahim
Journal:  Emerg Themes Epidemiol       Date:  2006-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.